Sarah Hendry/LinkedIn, Samuel Young/LinkedIn
Jun 13, 2026, 16:45
Sarah Hendry: A Big Day for Gene Therapy Research at EHA 2026
Sarah Hendry, Franchise Head, Hematology/Oncology at Spherix Global Insights, shared a post on LinkedIn:
”Pumped to be starting a packed day 2 at EHA 2026 with Samuel Young and Spherix Global Insights!
We have a poster presentation looking at gene therapy uptake dynamics in hemophilia and hemoglobinopathies tonight in poster hall A – hope to see you there!”
Stay updated with Hemostasis Today.
-
Nov 8, 2026, 14:55Andra T.: Antiphospholipid Syndrome and Its Thrombotic Risks
-
Nov 8, 2026, 14:06Shayan Mohammadmoradi: ZEUS Trial-Inflammation Reduction Without Fewer Cardiovascular Events
-
Nov 8, 2026, 14:05Kausik Ray: Plaque-Guided Care for Better Coronary Outcomes
-
Nov 8, 2026, 14:05Athira Elssa Johnson: Understanding Coronary Thrombosis and Its Risks
-
Nov 8, 2026, 14:04Sanjiv Beri: Blood Type Compatibility and the Balance of Giving and Receiving
-
Nov 8, 2026, 14:02Gabriela Hobbs: Recognizing Outstanding Abstract Achievements-ASH 2026
-
Nov 8, 2026, 12:22Marc Carrier: Advancing Catheter-Related Thrombosis Prevention Through Factor XI Inhibition
-
Nov 8, 2026, 11:56Why Genetic Predisposition Does Not Always Lead to Thrombosis – Stork Genetics
-
Nov 8, 2026, 11:45Sher-Lu Pai: Investigating Intracardiac Thrombosis and Its Management in Liver Transplantation